Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness

被引:111
作者
Dardenne, Etienne [2 ]
Pierredon, Sandra [1 ,3 ]
Driouch, Keltouma [4 ]
Gratadou, Lise [2 ]
Lacroix-Triki, Magali [1 ,3 ]
Espinoza, Micaela Polay [2 ]
Zonta, Eleonora [2 ]
Germann, Sophie [2 ]
Mortada, Hussein [2 ]
Villemin, Jean-Philippe [2 ]
Dutertre, Martin [2 ]
Lidereau, Rosette [4 ]
Vagner, Stephan [1 ,3 ]
Auboeuf, Didier [2 ]
机构
[1] Inst Claudius Regaud, INSERM, U563, Toulouse, France
[2] Ctr Rech Cancerol Lyon, INSERM, U1052, Lyon, France
[3] Inst Cancerol Gustave Roussy, INSERM, U981, Villejuif, France
[4] Hop Rene Huguenin, Inst Curie, Lab Oncogenet, St Cloud, France
关键词
HISTONE VARIANT MACROH2A; TRANSCRIPTIONAL COACTIVATOR; P68; CANCER; PROTEIN; EXPRESSION; OVEREXPRESSION; ISOFORMS; GROWTH;
D O I
10.1038/nsmb.2390
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Both epigenetic and splicing regulation contribute to tumor progression, but the potential links between these two levels of gene-expression regulation in pathogenesis are not well understood. Here, we report that the mouse and human RNA helicases Ddx17 and Ddx5 contribute to tumor-cell invasiveness by regulating alternative splicing of several DNA-and chromatin-binding factors, including the macroH2A1 histone. We show that macroH2A1 splicing isoforms differentially regulate the transcription of a set of genes involved in redox metabolism. In particular, the SOD3 gene that encodes the extracellular superoxide dismutase and plays a part in cell migration is regulated in an opposite manner by macroH2A1 splicing isoforms. These findings reveal a new regulatory pathway in which splicing factors control the expression of histone variant isoforms that in turn drive a transcription program to switch tumor cells to an invasive phenotype.
引用
收藏
页码:1139 / +
页数:9
相关论文
共 59 条
[1]
Abdelhaleem M, 2010, METHODS MOL BIOL, V587, P1, DOI 10.1007/978-1-60327-355-8_1
[2]
Redox regulation in cancer A double-edged sword with therapeutic potential [J].
Acharya, Asha ;
Das, Ila ;
Chandhok, Des ;
Saha, Tapas .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2010, 3 (01) :23-34
[3]
ASLAKSON CJ, 1992, CANCER RES, V52, P1399
[4]
The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor [J].
Bates, GJ ;
Nicol, SM ;
Wilson, BJ ;
Jacobs, AMF ;
Bourdon, JC ;
Wardrop, J ;
Gregory, DJ ;
Lane, DP ;
Perkins, ND ;
Fuller-Pace, FV .
EMBO JOURNAL, 2005, 24 (03) :543-553
[5]
Exon-Level Transcriptome Profiling in Murine Breast Cancer Reveals Splicing Changes Specific to Tumors with Different Metastatic Abilities [J].
Bemmo, Amandine ;
Dias, Christel ;
Rose, April A. N. ;
Russo, Caterina ;
Siegel, Peter ;
Majewski, Jacek .
PLOS ONE, 2010, 5 (08)
[6]
Cotranscriptional splicing potentiates the mRNA production from a subset of estradiol-stimulated genes [J].
Bittencourt, Danielle ;
Dutertre, Martin ;
Sanchez, Gabriel ;
Barbier, Jerome ;
Gratadou, Lise ;
Auboeuf, Didier .
MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (18) :5811-5824
[7]
The histone variant macroH2A is an epigenetic regulator of key developmental genes [J].
Buschbeck, Marcus ;
Uribesalgo, Iris ;
Wibowo, Indra ;
Rue, Pau ;
Martin, David ;
Gutierrez, Arantxa ;
Morey, Lluis ;
Guigo, Roderic ;
Lopez-Schier, Hernan ;
Di Croce, Luciano .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2009, 16 (10) :1074-U95
[8]
Phosphorylated p68 RNA helicase activates snail1 transcription by promoting HDAC1 dissociation from the snail1 promoter [J].
Carter, C. L. ;
Lin, C. ;
Liu, C-Y ;
Yang, L. ;
Liu, Z-R .
ONCOGENE, 2010, 29 (39) :5427-5436
[9]
Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours [J].
Causevic, M ;
Hislop, RG ;
Kernohan, NM ;
Carey, FA ;
Kay, RA ;
Steele, RJC ;
Fuller-Pace, FV .
ONCOGENE, 2001, 20 (53) :7734-7743
[10]
Extracellular/Microenvironmental Redox State [J].
Chaiswing, Luksana ;
Oberley, Terry D. .
ANTIOXIDANTS & REDOX SIGNALING, 2010, 13 (04) :449-465